A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

Keywords

MedicineGastroenterologyInternal medicineViremiaInterferonHepatitis C virusDiscontinuationRibavirinCirrhosisRandomized controlled trialInterferon alfaLiver biopsyTiterAlpha interferonHepatitis CImmunologyBiopsyVirus

Affiliated Institutions

Virginia Commonwealth University Medical Center US

Related Publications

Combination of interferon induction therapy and ribavirin in chronic hepatitis C

Peter Ferenci , H. Brünner , Karin Nachbaur +11 more

The initial clearance of hepatitis C virus (HCV) during interferon-alfa therapy is dose-dependent. Therefore, higher initial interferon doses (induction therapy) may improve tre...

2001 Hepatology 130 citations

A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

Karen L. Lindsay , Christian Trépo , Tobias Heintges +8 more

This international, randomized, active–controlled, parallel–group, double–blind dose–finding study compared peginterferon alfa–2b (PegIntron™) to interferon alfa–2b for the init...

2001 Hepatology 666 citations

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

E. Jenny Heathcote , Mitchell L. Shiffman , W. Graham E. Cooksley +9 more

In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 microg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 mill...

2000 New England Journal of Medicine 885 citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard , Patrick Marcellin , Samuel S. Lee +8 more

Only 15-20% of patients with chronic hepatitis C achieve a sustained virological response with interferon therapy. The aim of this study was to compare the efficacy and safety o...

1998 The Lancet 2330 citations

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns , John G. McHutchison , Stuart C. Gordon +7 more

A sustained virological response (SVR) rate of 41% has been achieved with interferon alfa-2b plus ribavirin therapy of chronic hepatitis C. In this randomised trial, peginterfer...

2001 The Lancet 6041 citations

Publication Info

Year: 1999
Type: article
Volume: 117
Issue: 5
Pages: 1164-1172
Citations: 253
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

253

OpenAlex

Cite This

APA Style

                            
                                
                                    Mitchell L. Shiffman, 
                                
                                    Charlotte M. Hofmann, 
                                
                                    Melissa J. Contos
                                
                                et al.
                            
                            (1999). 
                            A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. 
                            Gastroenterology
                            , 117
                            (5)
                            , 1164-1172.
                            https://doi.org/10.1016/s0016-5085(99)70402-6
                        

Identifiers

DOI: 10.1016/s0016-5085(99)70402-6